WILLIAM WALING: Open Payments
NPI 1104587559 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,271 in 68 payments from 13 companies in 2025. Trend: 2023 $1,208 · 2024 $2,709 · 2025 $2,271
Food & beverage: $2,271
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $349 |
| ABBVIE INC. | 4 | $286 |
| Axsome Therapeutics, Inc. | 4 | $286 |
| Neurocrine BioSciences, Inc. | 12 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $280 |
| E.R. Squibb & Sons, L.L.C. | 8 | $226 |
| Lundbeck LLC | 6 | $209 |
| Corium, LLC | 6 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
Products named: REXULTI, VRAYLAR, Auvelity, INGREZZA, CAPLYTA, COBENFY, Azstarys, FANAPT.
Industry payments across MI — which companies pay providers there.
